MAP1LC3B and hepatocellular carcinoma: In addition, our pathological analysis confirmed the molecular mechanism identified in our previous in vitro experiment, by which the stable knockdown of METTL3 increased expression of Ki67, LC3‐B, and VEGF‐A in HCC cells.